These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24981650)

  • 1. Mathematical modeling of the protein corona: implications for nanoparticulate delivery systems.
    Dell'Orco D; Lundqvist M; Linse S; Cedervall T
    Nanomedicine (Lond); 2014 May; 9(6):851-8. PubMed ID: 24981650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbohydrate-Based Nanocarriers Exhibiting Specific Cell Targeting with Minimum Influence from the Protein Corona.
    Kang B; Okwieka P; Schöttler S; Winzen S; Langhanki J; Mohr K; Opatz T; Mailänder V; Landfester K; Wurm FR
    Angew Chem Int Ed Engl; 2015 Jun; 54(25):7436-40. PubMed ID: 25940402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced biostability of nanoparticle-based drug delivery systems by albumin corona.
    Peng Q; Wei XQ; Yang Q; Zhang S; Zhang T; Shao XR; Cai XX; Zhang ZR; Lin YF
    Nanomedicine (Lond); 2015 Jan; 10(2):205-14. PubMed ID: 25600966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computer simulation of the role of protein corona in cellular delivery of nanoparticles.
    Ding HM; Ma YQ
    Biomaterials; 2014 Oct; 35(30):8703-10. PubMed ID: 25005681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the systemic drug delivery efficacy of nanoparticles using a transferrin variant for targeting.
    Chiu RY; Tsuji T; Wang SJ; Wang J; Liu CT; Kamei DT
    J Control Release; 2014 Apr; 180():33-41. PubMed ID: 24524898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive models of nanoparticle transport in solid tumors.
    Park K
    J Control Release; 2014 Oct; 192():325. PubMed ID: 25236391
    [No Abstract]   [Full Text] [Related]  

  • 7. Nanoparticle-mediated growth factor delivery systems: A new way to treat Alzheimer's disease.
    Lauzon MA; Daviau A; Marcos B; Faucheux N
    J Control Release; 2015 May; 206():187-205. PubMed ID: 25804873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug delivery to the CNS and polymeric nanoparticulate carriers.
    Costantino L
    Future Med Chem; 2010 Nov; 2(11):1681-701. PubMed ID: 21428839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein corona change the drug release profile of nanocarriers: the "overlooked" factor at the nanobio interface.
    Behzadi S; Serpooshan V; Sakhtianchi R; Müller B; Landfester K; Crespy D; Mahmoudi M
    Colloids Surf B Biointerfaces; 2014 Nov; 123():143-9. PubMed ID: 25262409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle-Protein Interaction: The Significance and Role of Protein Corona.
    Ahsan SM; Rao CM; Ahmad MF
    Adv Exp Med Biol; 2018; 1048():175-198. PubMed ID: 29453539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nanoparticle biomolecule corona: lessons learned - challenge accepted?
    Docter D; Westmeier D; Markiewicz M; Stolte S; Knauer SK; Stauber RH
    Chem Soc Rev; 2015 Oct; 44(17):6094-121. PubMed ID: 26065524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery.
    Tan ML; Choong PF; Dass CR
    Peptides; 2010 Jan; 31(1):184-93. PubMed ID: 19819278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A vision for cyclodextrin nanoparticles in drug delivery systems and pharmaceutical applications.
    Lakkakula JR; Maçedo Krause RW
    Nanomedicine (Lond); 2014 May; 9(6):877-94. PubMed ID: 24981652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time evolution of nanoparticle-protein corona in human plasma: relevance for targeted drug delivery.
    Barrán-Berdón AL; Pozzi D; Caracciolo G; Capriotti AL; Caruso G; Cavaliere C; Riccioli A; Palchetti S; Laganà A
    Langmuir; 2013 May; 29(21):6485-94. PubMed ID: 23631648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of the Protein Corona: The Interface between Nanoparticles and the Immune System.
    Barbero F; Russo L; Vitali M; Piella J; Salvo I; Borrajo ML; Busquets-Fité M; Grandori R; Bastús NG; Casals E; Puntes V
    Semin Immunol; 2017 Dec; 34():52-60. PubMed ID: 29066063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein Corona-Enabled Systemic Delivery and Targeting of Nanoparticles.
    Chen D; Ganesh S; Wang W; Amiji M
    AAPS J; 2020 Jun; 22(4):83. PubMed ID: 32495039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma protein adsorption and biological identity of systemically administered nanoparticles.
    Chen D; Ganesh S; Wang W; Amiji M
    Nanomedicine (Lond); 2017 Sep; 12(17):2113-2135. PubMed ID: 28805542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Particle Targeting in Complex Biological Media.
    Dai Q; Bertleff-Zieschang N; Braunger JA; Björnmalm M; Cortez-Jugo C; Caruso F
    Adv Healthc Mater; 2018 Jan; 7(1):. PubMed ID: 28809092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery".
    Mahon E; Salvati A; Baldelli Bombelli F; Lynch I; Dawson KA
    J Control Release; 2012 Jul; 161(2):164-74. PubMed ID: 22516097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gelatin-based nanoparticles as drug and gene delivery systems: reviewing three decades of research.
    Elzoghby AO
    J Control Release; 2013 Dec; 172(3):1075-91. PubMed ID: 24096021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.